Detail page

Knowledge Web

Person

Fabian Hauck (1976-)

Name	Fabian Hauck
Time	1976- (Date of birth and death)
Place	Deutschland
Variant	Fabian Harald Hauck
Further information	Diss. Medizinische Fakultät der Universität Würzburg. Habilitation, Medizinische Fakultät, Ludwig-Maximilians-Universität München, 2017
Record type	Person
GND-Identifier	130658111
Record ID	130658111
Involved in show all Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency Transition for adolescents with a rare disease: results of a nationwide German project DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T‐cell immunity Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API) Future directions in the diagnosis and treatment of APDS and IEI: a survey of German IEI centers Newborn screening for severe combined immunodeficiencies (SCID) in Germany = Neugeborenenscreening auf schwere kombinierte Immundefekte (SCID) in Deutschland Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API) Correction to: The Immune Deficiency and Dysregulation Activity (IDDA2.1 ‘Kaleidoscope’) Score and Other Clinical Measures in Inborn Errors of Immunity Der klinische Versorgungspfad zur multiprofessionellen Versorgung seltener Erkrankungen in der Pädiatrie – Ergebnisse aus dem Projekt TRANSLATE-NAMSE The Immune Deficiency and Dysregulation Activity (IDDA2.1 ‘Kaleidoscope’) Score and Other Clinical Measures in Inborn Errors of Immunity An Integrated clinical pathway for diagnosis, treatment and care of rare diseases: model, operating procedures, and results of the project TRANSLATE-NAMSE funded by the German Federal Joint Committee Upfront Enzyme Replacement via Erythrocyte Transfusions for PNP Deficiency Outcome of chronic granulomatous disease ‐ conventional treatment vs stem cell transplantation Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy SCID : Varianten und Therapieoptionen Regulation des Blimp1-Promotors durch die Transkriptionsfaktoren C-EBP-β [C-EBP-beta] und NFATc1 in T-Lymphozyten Regulation des Blimp1-Promotors durch die Transkriptionsfaktoren C-EBP-β [C-EBP-beta] und NFATc1 in T-Lymphozyten

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Fabian Hauck (1976-)

Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings

Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

Transition for adolescents with a rare disease: results of a nationwide German project

DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T‐cell immunity

Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)

Future directions in the diagnosis and treatment of APDS and IEI: a survey of German IEI centers

Newborn screening for severe combined immunodeficiencies (SCID) in Germany = Neugeborenenscreening auf schwere kombinierte Immundefekte (SCID) in Deutschland

Prospective newborn screening for SCID in Germany: A first analysis by the pediatric immunology working group (API)

Correction to: The Immune Deficiency and Dysregulation Activity (IDDA2.1 ‘Kaleidoscope’) Score and Other Clinical Measures in Inborn Errors of Immunity

Der klinische Versorgungspfad zur multiprofessionellen Versorgung seltener Erkrankungen in der Pädiatrie – Ergebnisse aus dem Projekt TRANSLATE-NAMSE

The Immune Deficiency and Dysregulation Activity (IDDA2.1 ‘Kaleidoscope’) Score and Other Clinical Measures in Inborn Errors of Immunity

An Integrated clinical pathway for diagnosis, treatment and care of rare diseases: model, operating procedures, and results of the project TRANSLATE-NAMSE funded by the German Federal Joint Committee

Upfront Enzyme Replacement via Erythrocyte Transfusions for PNP Deficiency

Outcome of chronic granulomatous disease ‐ conventional treatment vs stem cell transplantation

Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline

Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline

Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy

SCID : Varianten und Therapieoptionen

Regulation des Blimp1-Promotors durch die Transkriptionsfaktoren C-EBP-β [C-EBP-beta] und NFATc1 in T-Lymphozyten

Regulation des Blimp1-Promotors durch die Transkriptionsfaktoren C-EBP-β [C-EBP-beta] und NFATc1 in T-Lymphozyten